Newsfeeds Archive - Page 5 of 5

3 minute read

Daily Biotech Pulse: GSK’s Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion’s Schizophrenia Candidate

By Vandana Singh

July 28, 10:37 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ABBV

3 minute read

Recap of Monday’s Biotech Catalysts – End of the Day Summary

By Ragothaman Srinivasan

July 18, 6:07 PM

Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

ABBV

5 minute read

Tesla, Twitter And 76 Biggest Movers From Friday

By Lisa Levin

July 11, 7:30 AM

Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board recommended shareholders to approve a proposed plan sale.

ABEO

1 minute read

Here’s Why Acer Therapeutics Shares Are Moving

By Henry Khederian

July 8, 3:46 PM

Acer Therapeutics Inc (NASDAQ: ACER) shares are trading higher by 7.43% to $1.52 after the company and Relief Therapeutics announced the CNIPA issued a utility model patent covering dosage form claims related to ACER-001's polymer-coated formulation.

ACER

3 minute read

Tesla, WD-40 Company And 40 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

July 8, 12:20 PM

Gainers Aditxt, Inc. (NASDAQ: ADTX) shares surged 75.7% to $0.2812 after the company's Adimune therapeutic program completed a toxicology study indicating a favorable safety profile of ADI-100.

ACER

1 minute read

News

Acer Therapeutics and Relief Therapeutics Announce That The China National Intellectual Property Administration (CNIPA) Issued Utility Model Patent 11,202,767 Covering ACER-001 Dosage Form

By Bill Haddad

July 8, 8:34 AM

Acer Therapeutics Inc. (NASDAQ:ACER) (Acer) and its collaboration partner, RELIEF THERAPEUTICS Holding SA ((SIX: RLF, OTCQB:RLFTF, RLFTY)) (Relief), today announced that the China National Intellectual Property

ACER

4 minute read

Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates

By Shanthi Rexaline

July 1, 5:26 AM

The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled during the month, thanks to a reversal in broader market sentiment.

ACER